Shenzhen Cell Valley team visited Shanghai Enkai Cell Technology Co., LTD
On the afternoon of March 29, our chairman Shi Yuanyuan, chief scientist Wang Jianxun, deputy General manager Tang Xiaomeng and Vice Minister of research and Development Sun Rui went to Shanghai Enkai Cell Technology Co., LTD. (hereinafter referred to as "Enkai Drugs") to visit and exchange, Enkai Drugs President Xiao Weihua, CEO Tang Xiaodong, Executive director of strategic development Zhang CAI, research and development director Wang Yuane warmly received and held a symposium.
Enkesai Pharmaceuticals and Shenzhen Cell Valley began a comprehensive strategic cooperation in September 2022 to jointly promote new drug research and development in the field of CAR-NK. At this symposium, Professor Xiao Weihua introduced the current situation of the production and research and development of Enkesai drugs, and the two sides discussed the relevant progress and technical issues of the existing cooperation projects, and clarified the next work and cooperation plan.
